Wnt signaling in cancer.
Open accessThe DOI matches its Crossref record; 90 of the 94 references it cites were found in a registry or an index.
Abstract
Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biology. From the earliest observation that Wnt overexpression could lead to malignant transformation of mouse mammary tissue to the most recent genetic discoveries gleaned from tumor genome sequencing, the Wnt pathway continues to evolve as a central mechanism in cancer biology. This article summarizes the evidence supporting a role for Wnt signaling in human cancer. This includes a review of the genetic mutations affecting Wnt pathway components, as well as some of epigenetic mechanisms that alter expression of genes relevant to Wnt. I also highlight some research on the cooperativity of Wnt with other signaling pathways in cancer. Finally, some emphasis is placed on laboratory research that provides a proof of concept for the therapeutic inhibition of Wnt signaling in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, APC, as a gene that upregulates WNT signaling, is negatively correlated with the frequency of T cell infiltration [196,197,198].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429 · cited 1×
“Expression of the Wnt receptor FZD7 is characteristic of these types of breast cancer (Sorlie et al. 2003).”
BackgroundWnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666 · cited 1×
“The impact ofb-catenin knockdown in cancers without identifiable genetic lesions in Wnt signaling could relate to the purported role of Wnt in the establishment and maintenance of so-called cancer stem cells (CSCs) (Reya and Clevers 2005; Malanchi and Huelsken 2009).”
Backgroundβ-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601 · cited 1×
“Consequently, inhibition of target gene activation in colorectal cancer cells expressing the dominant negative TCF4 resulted in their growth arrest (Tetsu and McCormick 1999; van de Wetering et al. 2002).”
BackgroundThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169 · cited 1×
“Paradoxically, mutations in TCF4, identified through genomic sequencing efforts of colorectal cancers, appear to be inactivating by compromising its ability to repress cell growth (Sjoblom et al. 2006; Tang et al. 2008).”
BackgroundThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“PKM2 has received considerable attention lately, although mainly because of a renewed interest in the role of metabolism and aerobic glycolysis in cancer (Christofk et al. 2008).”
BackgroundThe β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.-P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01014-0 · Cited by 2,030
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595 · cited 1×
“Ultimately, the TCF transcription factors that associated with b-catenin completed the understanding of a basic signaling pathway that could account for the potent tumori- genic effects of Wnt (reviewed by Klaus and Birchmeier 2008).”
Backgroundvan Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543 · cited 1×
“The impact of Notch in the intestine was consistent with previous work showing that its activation or inhibition increased or decreased the population of proliferating/progenitor cells, respectively, at the expense of the differentiated population (Fre et al. 2005; van Es et al. 2005).”
ResultMorin, R. D., Johnson, N. A., Severson, T. M., Mungall, A. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,521
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 1×
“Granulocyticmacrophage progenitors isolated from CML patients show attributes of excessive Wnt signaling relative to normal progenitors and the introduction of the Wnt pathway inhibitor Axin decreased their capacity for proliferation and self-renewal (Jamieson et al. 2004).”
BackgroundCancer epigenetics reaches mainstream oncology
Rodríguez-Paredes, M., & Esteller, M. (2011) · Nature Medicine · doi:10.1038/nm.2305 · Cited by 1,205
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Yang, W., Xia, Y., Ji, H., Zheng, Y., Liang, J., Huang, W., Gao, X., Aldape, K., & Lu, Z. (2011) · Nature · doi:10.1038/nature10598 · Cited by 1,028 · cited 2×
“2A) (Yang et al. 2011b).”
BackgroundSatoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000) · Nature Genetics · doi:10.1038/73448 · Cited by 960 · cited 3×
“Similarly, ectopic expression of Axin1, an additional tumor suppressor in the Wnt pathway, promoted apoptosis in colorectal and PGE2 LR P 5/ 6 E G F R Wnt fzd EP2 PKM2 src src PKM2 PKM2 P P PMGsα Gsα β-cat β-cat β-cat β-cat Cyclin D1 TCF ON HDAC3 β-cat GSK3 AA PGE2 COX2 PGDH Inactive TCF TCF OFFON COX2 PGDH AXIN A B P…”
BackgroundInfluentialInactivating mutations of acetyltransferase genes in B-cell lymphoma
Pasqualucci, L., Dominguez-Sola, D., Chiarenza, A., Fabbri, G., Grunn, A., Trifonov, V., Kasper, L. H., Lerach, S., Tang, H., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09730 · Cited by 949 · cited 1×
“Mutations in the gene coding for the CREB binding protein (CREBBP/CBP) have been identified in acute lypmhoblastic leukemia and B-cell lymphoma (Mullighan et al. 2011; Pasqualucci et al. 2011).”
BackgroundNotch signals control the fate of immature progenitor cells in the intestine
Fre, S., Huyghe, M., Mourikis, P., Robine, S., Louvard, D., & Artavanis-Tsakonas, S. (2005) · Nature · doi:10.1038/nature03589 · Cited by 935 · cited 1×
“The impact of Notch in the intestine was consistent with previous work showing that its activation or inhibition increased or decreased the population of proliferating/progenitor cells, respectively, at the expense of the differentiated population (Fre et al. 2005; van Es et al. 2005).”
ResultProstaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883 · cited 2×
“Mechanistic proposals for the interaction between prostaglandin and Wnt signaling include COX2 as a direct target gene of Wnt signaling, PPARDelta as a convergent focal point for the two pathways, and stimulation of the Wnt pathway by crosstalk from the EP2 prostaglandin receptor (Araki et al. 2003; Wang et al. 2004;…”
BackgroundThe many ways of Wnt in cancer
Polakis, P. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.007 · Cited by 866 · cited 4×
“Regulation of b-catenin also fails when b-catenin itself contains mutations that prevent it from being marked for destruction by the kinases (Polakis 2007).”
BackgroundInfluentialSelf-citationSuzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M. P., Herman, J. G., & Baylin, S. B. (2002) · Nature Genetics · doi:10.1038/ng892 · Cited by 857 · cited 1×
“Indeed, genome-wide analysis of promotor DNA methylation in human medulloblastoma, colon, and pancreatic cancers showed that Wnt pathway inhibitors are common targets of this mechanism of gene repression (Kongkham et al. 2010; Vincent et al. 2011; Suzuki et al. 2002).”
BackgroundSomatic mutations of the histone H3K27 demethylase gene UTX in human cancer
van Haaften, G., Dalgliesh, G. L., Davies, H., Chen, L., Bignell, G., Greenman, C., Edkins, S., Hardy, C., O'Meara, S., Teague, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.349 · Cited by 784 · cited 1×
“This is particularly intriguing because somatic mutations in EZH2, as well as another H3k27 methyltransferase, UTX, have been detected in a variety of human cancers (van Haaften et al. 2009; Morin et al. 2011).”
BackgroundLin, S.-Y., Xia, W., Wang, J. C., Kwong, K. Y., Spohn, B., Wen, Y., Pestell, R. G., & Hung, M.-C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060025397 · Cited by 783 · cited 2×
“hyperactive signaling is apparent, particularly in cancers classified as basal-like or triple negative type (Lin et al. 2000; Chung et al. 2004; Howe and Brown 2004; Khramtsov et al. 2010; Geyer et al. 2011).”
BackgroundAspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2
Chan, A. T., Ogino, S., & Fuchs, C. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067208 · Cited by 781 · cited 2×
“…involving the use genetically engineered mouse models of cancer, as well as expansive human studies on nonsteroidal anti-inflammatory drugs (NSAIDS) and cancer risk, have firmly established a role for prostaglandin signaling in colorectal tumorigenesis (Oshima and Taketo 2002; Chan et al. 2007).”
BackgroundThe Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Wang, Y., Krivtsov, A. V., Sinha, A. U., North, T. E., Goessling, W., Feng, Z., Zon, L. I., & Armstrong, S. A. (2010) · Science · doi:10.1126/science.1186624 · Cited by 763 · cited 1×
“In another mouse model of leukemia, initiated by expression of a mixed lineage leukemia (MLL) fusion protein, the conditional ablation of the b-catenin gene prevented preleukemic stem cells from inducing leukemia in grafted animals (Wang et al. 2010).”
BackgroundSuppression of intestinal neoplasia by DNA hypomethylation
Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Edward Jung, W., Li, E., Weinberg, R. A., & Jaenisch, R. (1995) · Cell · doi:10.1016/0092-8674(95)90329-1 · Cited by 710 · cited 2×
“…on Wnt-driven tumorigenesis was Cite this article as Cold Spring Harb Perspect Biol 2012;4:a008052 3 reported by Laird et al., who found that genetic depletion and pharmacological suppression of DNA methyl transferase effectively reduced the tumor burden in the APC min mouse (Laird et al. 1995).”
BackgroundMutations in AXIN2 Cause Familial Tooth Agenesis and Predispose to Colorectal Cancer
Lammi, L., Arte, S., Somer, M., Järvinen, H., Lahermo, P., Thesleff, I., Pirinen, S., & Nieminen, P. (2004) · The American Journal of Human Genetics · doi:10.1086/386293 · Cited by 691 · cited 2×
“Axins I and II are also tumor suppressors found mutated in both sporadic cancers, particularly hepatocellar and some colorectal, as well as in some familial cancer syndromes (Lammi et al. 2004; Salahshor and Woodgett 2005; Marvin et al. 2011).”
BackgroundCREBBP mutations in relapsed acute lymphoblastic leukaemia
Mullighan, C. G., Zhang, J., Kasper, L. H., Lerach, S., Payne-Turner, D., Phillips, L. A., Heatley, S. L., Holmfeldt, L., Collins-Underwood, J. R., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09727 · Cited by 637 · cited 1×
“Mutations in the gene coding for the CREB binding protein (CREBBP/CBP) have been identified in acute lypmhoblastic leukemia and B-cell lymphoma (Mullighan et al. 2011; Pasqualucci et al. 2011).”
BackgroundWNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis
Nguyen, D. X., Chiang, A. C., Zhang, X. H.-F., Kim, J. Y., Kris, M. G., Ladanyi, M., Gerald, W. L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.04.030 · Cited by 613 · cited 1×
“Work from the Massague laboratory encourages us to target Wnt signaling in lung cancer, which again typically lacks pathway mutations (Nguyen et al. 2009).”
BackgroundCutaneous cancer stem cell maintenance is dependent on β-catenin signalling
Malanchi, I., Peinado, H., Kassen, D., Hussenet, T., Metzger, D., Chambon, P., Huber, M., Hohl, D., Cano, A., Birchmeier, W., et al. (2008) · Nature · doi:10.1038/nature06835 · Cited by 597 · cited 1×
“The Huelsken laboratory found many similarities between normal skin stem cells and cancer stem cells isolated from murine epidermal tumors induced by carcinogens (Malanchi et al. 2008).”
BackgroundLoss of β-Catenin Impairs the Renewal of Normal and CML Stem Cells In Vivo
Zhao, C., Blum, J., Chen, A., Kwon, H. Y., Jung, S. H., Cook, J. M., Lagoo, A., & Reya, T. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.003 · Cited by 592
Wnt signaling: is the party in the nucleus?
Willert, K., & Jones, K. A. (2006) · Genes & Development · doi:10.1101/gad.1424006 · Cited by 589 · cited 1×
“The carboxyl terminus of b-catenin is known to recruit numerous chromatin-remodeling subunits, such as set1 and paf1, that mediate the H3K4me3 histone marks associated with highly active genes (Willert and Jones 2006).”
BackgroundGottardi, C. J., Wong, E., & Gumbiner, B. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1049 · Cited by 544 · cited 1×
“Gottardi et al. (2001), exploited the mutually exclusive binding of bcatenin to E-cadherin and the TCF transcription factors by expressing cadherin chimeras that block the latter interaction.”
BackgroundWnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
Khramtsov, A. I., Khramtsova, G. F., Tretiakova, M., Huo, D., Olopade, O. I., & Goss, K. H. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091125 · Cited by 509
Apoptosis and APC in colorectal tumorigenesis.
Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7950 · Cited by 489 · cited 1×
“On induction, the growth of cultured HT29 cells was inhibited by the wild-type APC, which was attributed to an increase in apoptosis (Morin et al. 1996).”
BackgroundLilien, J., & Balsamo, J. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.009 · Cited by 465 · cited 1×
“Previously, EGFR-mediated phoshorylation of b-catenin on Y-654 had been reported to affect its interaction with cadherins and also correlated with an increase inb-catenin-mediated transcriptional activity (Lilien and Balsamo 2005).”
BackgroundWilms Tumor Suppressor WTX Negatively Regulates WNT/ß-Catenin Signaling
Major, M. B., Camp, N. D., Berndt, J. D., Yi, X., Goldenberg, S. J., Hubbert, C., Biechele, T. L., Gingras, A.-C., Zheng, N., MacCoss, M. J., et al. (2007) · Science · doi:10.1126/science/1141515 · Cited by 405 · cited 1×
“More recently, WTX has joined APC, Axin, and b-TrCP as a part of the so-called b-catenin destruction complex (Major et al. 2007).”
BackgroundTargeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Ni, M., Chen, Y., Lim, E., Wimberly, H., Bailey, S. T., Imai, Y., Rimm, D. L., Shirley Liu, X., & Brown, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.026 · Cited by 397 · cited 1×
“Cooperativity between the androgen receptor (AR) and Wnt signaling was proposed as a mechanism for the potentiation of EGF receptor tyrosine kinase family signaling in ER-/ Her2þ breast cancers (Ni et al. 2011).”
BackgroundGeyer, F. C., Lacroix-Triki, M., Savage, K., Arnedos, M., Lambros, M. B., MacKay, A., Natrajan, R., & Reis-Filho, J. S. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.205 · Cited by 373 · cited 2×
“hyperactive signaling is apparent, particularly in cancers classified as basal-like or triple negative type (Lin et al. 2000; Chung et al. 2004; Howe and Brown 2004; Khramtsov et al. 2010; Geyer et al. 2011).”
BackgroundNotch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine
Fre, S., Pallavi, S. K., Huyghe, M., Laé, M., Janssen, K.-P., Robine, S., Artavanis-Tsakonas, S., & Louvard, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900427106 · Cited by 345 · cited 2×
“Gottardi et al. (2001), exploited the mutually exclusive binding of bcatenin to E-cadherin and the TCF transcription factors by expressing cadherin chimeras that block the latter interaction.”
BackgroundWnt Signaling and Breast Cancer
Howe, L. R., & Brown, A. M. C. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.1.561 · Cited by 342
Verma, U. N., Surabhi, R. M., Schmaltieg, A., Becerra, C. R., & Gaynor, R. B. (2003) · PubMed · Cited by 328
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells
Bafico, A., Liu, G., Goldin, L., Harris, V., & Aaronson, S. A. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.032 · Cited by 324 · cited 2×
“The latter possibility was first made apparent by Bafico et al. (2004), when they reported autocrine Wnt signaling in a panel of breast and ovarian cancer cell lines, MDAMB-231 among them.”
BackgroundRegulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki, Y., Okamura, S., Hussain, S. P., Nagashima, M., He, P., Shiseki, M., Miura, K., & Harris, C. C. (2003) · PubMed · Cited by 322
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion
Bass, A. J., Lawrence, M. S., Brace, L. E., Ramos, A. H., Drier, Y., Cibulskis, K., Sougnez, C., Voet, D., Saksena, G., Sivachenko, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.936 · Cited by 309 · cited 2×
“In a colorectal cancer genome sequencing effort, the Meyerson laboratory recently reported a rare, but recurring rearrangement in which the TCF4 gene TCFL72 was fused to VTI1A (Bass et al. 2011).”
BackgroundFZD7 has a critical role in cell proliferation in triple negative breast cancer
Yang, L., Wu, X., Wang, Y., Zhang, K., Wu, J., Yuan, Y.-C., Deng, X., Chen, L., Kim, C. C. H., Lau, S., et al. (2011) · Oncogene · doi:10.1038/onc.2011.145 · Cited by 297 · cited 2×
“2A) (Yang et al. 2011b).”
BackgroundConvergence between Wnt-β-catenin and EGFR signaling in cancer
Hu, T., & Li, C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-236 · Cited by 291 · cited 1×
“These include direct binding of b-catenin to EGFR, modulation of the cadherin-b-catenin interface by EGFR, activation ofb-catenin-dependent signaling by EGFR through PI3K signaling as well as the EGFR gene itself as a Wnt target (review by Hu and Li 2011).”
BackgroundMcGarvey, K. M., Fahrner, J. A., Greene, E., Martens, J., Jenuwein, T., & Baylin, S. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2481 · Cited by 286 · cited 1×
“Considering that DNA hypermethylation of promotor regions is frequently accompanied by chromatin modifications, it is not surprising that the sSFRP1 gene is also a target of chromatin modifying factors (McGarvey et al. 2006).”
BackgroundNotch post-translationally regulates β-catenin protein in stem and progenitor cells
Kwon, C., Cheng, P., King, I. N., Andersen, P., Shenje, L., Nigam, V., & Srivastava, D. (2011) · Nature Cell Biology · doi:10.1038/ncb2313 · Cited by 284 · cited 2×
“laboratory recently offered an unexpected mechanism for cooperativity between Wnt and Notch signaling (Kwon et al. 2011).”
BackgroundWilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene
Huff, V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3002 · Cited by 266 · cited 2×
“This is 2 Cite this article as Cold Spring Harb Perspect Biol 2012;4:a008052 particularly intriguing as WTX is a tumor suppressor associated with the pediatric renal cancer Wilm’s tumor, which is also commonly associated with b-catenin mutations (Huff 2011).”
Background15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis
Myung, S.-J., Rerko, R. M., Yan, M., Platzer, P., Guda, K., Dotson, A., Lawrence, E., Dannenberg, A. J., Lovgren, A. K., Luo, G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603235103 · Cited by 264 · cited 2×
“Therefore, it acts opposite to COX2, and knockout of 15PGDH in the APCmin mouse dramatically increases tumor burden, further fortifying the case for prostaglandins as intestinal tumor promotors (Myung et al. 2006).”
BackgroundYou, L., He, B., Xu, Z., Uematsu, K., Mazieres, J., Mikami, I., Reguart, N., Moody, T. W., Kitajewski, J., McCormick, F., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207844 · Cited by 258 · cited 1×
“In an additional pharmacological test, You et al. (2004), inhibited the growth of a human melanoma xenograft model by administering a monoclonal antibody to Wnt2.”
BackgroundThe links between axin and carcinogenesis
Salahshor, S., & Woodgett, J. R. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.009506 · Cited by 249 · cited 2×
“Axins I and II are also tumor suppressors found mutat- ed in both sporadic cancers, particularly hepatocellar and some colorectal, as well as in some familial cancer syndromes (Lammi et al. 2004; Salahshor and Woodgett 2005; Marvin et al. 2011).”
BackgroundThe Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators
Teo, J.-L., & Kahn, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.012 · Cited by 248 · cited 2×
“This is of interest to Wnt signaling as CBP associates directly with the carboxy-terminal sequence in b-catenin and CBP/ b-catenin mediated transcription has been proposed to be critical for stem cell/progenitor cell maintenance and proliferation (Teo and Kahn 2011).”
BackgroundGlycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation
Abrahamsson, A. E., Geron, I., Gotlib, J., Dao, K.-H. T., Barroga, C. F., Newton, I. G., Giles, F. J., Durocher, J., Creusot, R. S., Karimi, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900189106 · Cited by 246 · cited 3×
“…Truncation/ missense Inactive acetyltransferase Lymphoma/ leukemia Teo and Kahn 2011 GSK3b Missplicing, inframe deletion Inactive kinase Leukemia Abrahamsson et al. 2009 LRP5 Missplicing, inframe deletion Loss of repression by DKK1 Breast/parathyroid Bjorklund et al. 2009 TCF7L2 (TCF4)…”
BackgroundFrequent epigenetic inactivation of Wnt antagonist genes in breast cancer
Suzuki, H., Toyota, M., Caraway, H., Gabrielson, E., Ohmura, T., Fujikane, T., Nishikawa, N., Sogabe, Y., Nojima, M., Sonoda, T., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604259 · Cited by 238 · cited 1×
“Members of the sFRP family have also been reported to be silenced by DNA methylation in numerous other cancers including hepatocellular cancer, breast cancer, and melanoma (Suzuki et al. 2008; Takagi et al. 2008; Ekstrom et al. 2011).”
BackgroundJiang, X., Tan, J., Li, J., Kivimäe, S., Yang, X., Zhuang, L., Lee, P. L., Chan, M. T. W., Stanton, L. W., Liu, E. T., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.019 · Cited by 235 · cited 1×
“DACT3 is an additional inhibitor of Wnt signaling that is repressed in colon cancers by histone modification (Jiang et al. 2008).”
BackgroundWilms tumor genetics: Mutations in WT1, WTX, and CTNNB1 account for only about one‐third of tumors
Ruteshouser, E. C., Robinson, S. M., & Huff, V. (2008) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20553 · Cited by 215 · cited 2×
“That both WTX and b-catenin mutations coexist in some Wilm’s tumors suggests the two genes are not strictly functionally redundant (Ruteshouser et al. 2008).”
BackgroundCheng, A. S. L., Lau, S. S., Chen, Y., Kondo, Y., Li, M. S., Feng, H., Ching, A. K., Cheung, K. F., Wong, H. K., Tong, J. H., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3342 · Cited by 208 · cited 2×
“In the case of AML, it was proposed that chromatin modification resulted from the targeting of the sFRP1 gene by the RUNXETO fusion protein (Cheng et al. 2011b).”
Backgroundβ -catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis
van Veelen, W., Le, N. H., Helvensteijn, W., Blonden, L., Theeuwes, M., Bakker, E. R. M., Franken, P. F., van Gurp, L., Meijlink, F., van der Valk, M. A., et al. (2011) · Gut · doi:10.1136/gut.2010.233460 · Cited by 183
Tang, W., Dodge, M., Gundapaneni, D., Michnoff, C., Roth, M., & Lum, L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804709105 · Cited by 178 · cited 1×
“Paradoxically, mutations in TCF4, identified through genomic sequencing efforts of colorectal cancers, appear to be inactivating by compromising its ability to repress cell growth (Sjoblom et al. 2006; Tang et al. 2008).”
BackgroundVincent, A., Omura, N., Hong, S.-M., Jaffe, A., Eshleman, J., & Goggins, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3431 · Cited by 177 · cited 1×
“Indeed, genome-wide analysis of promotor DNA methylation in human medulloblastoma, colon, and pancreatic cancers showed that Wnt pathway inhibitors are common targets of this mechanism of gene repression (Kongkham et al. 2010; Vincent et al. 2011; Suzuki et al. 2002).”
BackgroundDeficiency of Mbd2 suppresses intestinal tumorigenesis
Sansom, O. J., Berger, J., Bishop, S. M., Hendrich, B., Bird, A., & Clarke, A. R. (2003) · Nature Genetics · doi:10.1038/ng1155 · Cited by 176 · cited 1×
“Subsequent studies with this model revealed that deficiency of the methyl–CpG binding repressor Mbd2 also severely repressed tumor formation by attenuating Wnt signaling (Sansom et al. 2003; Phesse et al. 2008).”
BackgroundMatsuda, Y., Schlange, T., Oakeley, E. J., Boulay, A., & Hynes, N. E. (2009) · Breast Cancer Research · doi:10.1186/bcr2317 · Cited by 166 · cited 1×
“This suggests that Wnt ligands might drive certain breast cancers and is consistent with previous work from the Hynes laboratory (Matsuda et al. 2009).”
ResultThe Soluble Wnt Receptor Frizzled8CRD-hFc Inhibits the Growth of Teratocarcinomas In vivo
DeAlmeida, V. I., Li, M., Ernst, J. A., Koeppen, H., Polakis, P. G., & Rubinfeld, B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0266 · Cited by 151
Self-citationAkiri, G., Cherian, M. M., Vijayakumar, S., Liu, G., Bafico, A., & Aaronson, S. A. (2009) · Oncogene · doi:10.1038/onc.2009.82 · Cited by 150 · cited 1×
“These investigators subsequently reported autocrine signaling in non-small cell lung cancers, as well (Akiri et al. 2009).”
BackgroundAngus-Hill, M. L., Elbert, K. M., Hidalgo, J., & Capecchi, M. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102300108 · Cited by 128
siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and Survival
Zeng, G., Apte, U. M., Cieply, B. W., Singh, S., & Monga, S. P. (2007) · Neoplasia · doi:10.1593/neo.07469 · Cited by 122 · cited 1×
“In the HepG2 human hepatoma cell line, RNAi mediated knockdown of b-catenin decreased cell viability, proliferation and growth in soft agar (Zeng et al. 2007).”
BackgroundFrequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma
Takagi, H., Sasaki, S., Suzuki, H., Toyota, M., Maruyama, R., Nojima, M., Yamamoto, H., Omata, M., Tokino, T., Imai, K., et al. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2170-0 · Cited by 121 · cited 1×
“Members of the sFRP family have also been reported to be silenced by DNA methylation in numerous other cancers including hepatocellular cancer, breast cancer, and melanoma (Suzuki et al. 2008; Takagi et al. 2008; Ekstrom et al. 2011).”
BackgroundKongkham, P. N., Northcott, P. A., Croul, S. E., Smith, C. A., Taylor, M. D., & Rutka, J. T. (2010) · Oncogene · doi:10.1038/onc.2010.32 · Cited by 116 · cited 1×
“Indeed, genome-wide analysis of promotor DNA methylation in human medulloblastoma, colon, and pancreatic cancers showed that Wnt pathway inhibitors are common targets of this mechanism of gene repression (Kongkham et al. 2010; Vincent et al. 2011; Suzuki et al. 2002).”
BackgroundSuppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
Roh, H., Green, D. W., Boswell, C., Pippin, J. A., & Drebin, J. A. (2001) · PubMed · Cited by 107
Mahmoudi, T., Boj, S. F., Hatzis, P., Li, V. S. W., Taouatas, N., Vries, R. G. J., Teunissen, H., Begthel, H., Korving, J., Mohammed, S., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000539 · Cited by 95 · cited 1×
“Although many of these sorts of modifiers are commonly associated with gene activation by transcription factors, the Clevers laboratory reported that the MLLT10/AF10-DOT1L complex was principally dedicated to Wnt signaling (Mahmoudi et al. 2011).”
BackgroundAXIN2-associated autosomal dominant ectodermal dysplasia and neoplastic syndrome
Marvin, M. L., Mazzoni, S. M., Herron, C. M., Edwards, S. P., Gruber, S. B., & Petty, E. M. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33927 · Cited by 93 · cited 2×
“Axins I and II are also tumor suppressors found mutated in both sporadic cancers, particularly hepatocellar and some colorectal, as well as in some familial cancer syndromes (Lammi et al. 2004; Salahshor and Woodgett 2005; Marvin et al. 2011).”
BackgroundA protein knockdown strategy to study the function of β-catenin in tumorigenesis
Cong, F., Zhang, J., Pao, W. J., Zhou, P., & VARMUS, H. E. (2003) · BMC Molecular Biology · doi:10.1186/1471-2199-4-10 · Cited by 82
Kim, J.-S., Crooks, H., Foxworth, A., & Waldman, T. A. (2002) · PubMed · Cited by 81
COX Selectivity and Animal Models for Colon Cancer
Oshima, M., & Taketo, M. M. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394953 · Cited by 77
Ashihara, E., Kawata, E., Nakagawa, Y., Shimazaski, C., Kuroda, J., Taniguchi, K., Uchiyama, H., Tanaka, R., Yokota, A., Takeuchi, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1350 · Cited by 73 · cited 1×
“Ashihara et al. (2009) provided an additional example in which interference with Wnt signaling impaired the tumorigencity of cancer cells lacking Wnt pathway mutations.”
Backgroundβ‐Catenin and p53 analyses of a breast carcinoma tissue microarray
Chung, G. G., Zerkowski, M. P., Ocal, I. T., Dolled-Filhart, M. P., Kang, J. J., Psyrri, A. K., Camp, R. L., & Rimm, D. L. (2004) · Cancer · doi:10.1002/cncr.20232 · Cited by 72 · cited 2×
“hyperactive signaling is apparent, particularly in cancers classified as basal-like or triple negative type (Lin et al. 2000; Chung et al. 2004; Howe and Brown 2004; Khramtsov et al. 2010; Geyer et al. 2011).”
BackgroundThe Internally Truncated LRP5 Receptor Presents a Therapeutic Target in Breast Cancer
Björklund, P., Svedlund, J., Olsson, A., Åkerström, G., & Westin, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004243 · Cited by 70 · cited 3×
“…inframe deletion Inactive kinase Leukemia Abrahamsson et al. 2009 LRP5 Missplicing, inframe deletion Loss of repression by DKK1 Breast/parathyroid Bjorklund et al. 2009 TCF7L2 (TCF4) Missense/deletion/ truncation Loss of repression Colorectal Cuilliere-Dartigues et al. 2006 TCF7L2 (TCF4) Fusion…”
BackgroundDeficiency of Mbd2 Attenuates Wnt Signaling
Phesse, T. J., Parry, L., Reed, K. R., Ewan, K., Dale, T. C., Sansom, O. J., & Clarke, A. R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00539-08 · Cited by 69 · cited 1×
“Subsequent studies with this model revealed that deficiency of the methyl–CpG binding repressor Mbd2 also severely repressed tumor formation by attenuating Wnt signaling (Sansom et al. 2003; Phesse et al. 2008).”
BackgroundGreen, D. W., Roh, H., Pippin, J. A., & Drebin, J. A. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2001.6241 · Cited by 66 · cited 1×
“Suppression of b-catenin by antisense oligonucleotides was also found to inhibit tumorgenicity of colon cancer cells in vitro and in vivo (Green et al. 2001; Roh et al. 2001).”
BackgroundDartigues, P., El-Bchiri, J., Krimi, A., Buhard, O., Fontanges, P., Fléjou, J., Hamelin, R., & Duval, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209471 · Cited by 65 · cited 3×
“…of repression by DKK1 Breast/parathyroid Bjorklund et al. 2009 TCF7L2 (TCF4) Missense/deletion/ truncation Loss of repression Colorectal Cuilliere-Dartigues et al. 2006 TCF7L2 (TCF4) Fusion with VT11A gene Unclear Colorectal Bass 2011 FAB123B (WTX) Truncation/ deletion Loss of function…”
BackgroundClements, W. M., Lowy, A. M., & Groden, J. L. (2003) · Clinical Colorectal Cancer · doi:10.3816/ccc.2003.n.018 · Cited by 62 · cited 2×
“Genetic alterations in Wnt signaling in cancer Affected gene DNA/mRNA alteration Functional outcome Cancer type Reference CTNNBl (bcatenin) Missense/in-frame deletion Enhanced protein stability Hepatocellular/ Medulloblastoma Polakis 2007 APC (APC) Truncation Reduced regulatory activity Colorectal/gastric Clements et…”
BackgroundMologni, L., Dekhil, H., Ceccon, M., Purgante, S., Lan, C., Cleris, L., Magistroni, V., Formelli, F., & Gambacorti-Passerini, C. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1108 · Cited by 59 · cited 1×
“In a separate study, knockdown ofbcatenin by inducible shRNA strongly inhibited proliferation of HCT116 and Ls174t colorectal cancer cells, both of which harbor mutant bcatenin alleles (Mologni et al. 2010).”
BackgroundSmartt, H. J. M., Greenhough, A., Ordóñez‐Morán, P., Talero, E., Cherry, C. A., Wallam, C. A., Parry, L., Kharusi, M. A., Roberts, H. R., Mariadason, J. M., et al. (2011) · Gut · doi:10.1136/gutjnl-2011-300817 · Cited by 51 · cited 1×
“In a recent study, the Paraskeva lab offered an additional mechanism for the interaction of the prostaglandin and Wnt signals by showing that the 15-PGDH gene is a target of b-catenin-dependent repression (Smartt et al. 2011).”
BackgroundThe WTX Tumor Suppressor Regulates Mesenchymal Progenitor Cell Fate Specification
Moisan, A., Rivera, M. N., Lotinun, S., Akhavanfard, S., Coffman, E. J., Cook, E., Stoykova, S., Mukherjee, S., Schoonmaker, J. A., Burger, A., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.03.013 · Cited by 51 · cited 1×
“In a recent developmental study in mice, germline inactivation of WTX resulted in the accumulation of multipotent mesenchymal precursor cells resulting from aberrant b-catenin activation (Moisan et al. 2011).”
BackgroundCancer stem cells: never Wnt away from the niche
Malanchi, I., & Huelsken, J. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32831d1faf · Cited by 49 · cited 1×
“The impact ofb-catenin knockdown in cancers without identifiable genetic lesions in Wnt signaling could relate to the purported role of Wnt in the establishment and maintenance of so-called cancer stem cells (CSCs) (Reya and Clevers 2005; Malanchi and Huelsken 2009).”
BackgroundEkström, E. J., Sherwood, V., & Andersson, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018674 · Cited by 47 · cited 1×
“Members of the sFRP family have also been reported to be silenced by DNA methylation in numerous other cancers including hepatocellular cancer, breast cancer, and melanoma (Suzuki et al. 2008; Takagi et al. 2008; Ekstrom et al. 2011).”
BackgroundWnt and Cyclooxygenase-2 Cross-talk Accelerates Adenoma Growth
Wang, D., Mann, J. R., & DuBois, R. N. (2004) · Cell Cycle · doi:10.4161/cc.3.12.1288 · Cited by 44 · cited 2×
“Mechanistic proposals for the interaction between prostaglandin and Wnt signaling include COX2 as a direct target gene of Wnt signaling, PPARDelta as a convergent focal point for the two pathways, and stimulation of the Wnt pathway by crosstalk from the EP2 prostaglandin receptor (Araki et al. 2003; Wang et al. 2004;…”
BackgroundCheng, C. K., Li, L., Cheng, S. H., Ng, K., Chan, N. P. H., Ip, R. K. L., Wong, R. S. M., Shing, M. M. K., Li, C. K., & Ng, M. H. L. (2011) · Blood · doi:10.1182/blood-2011-05-354712 · Cited by 42 · cited 2×
“In the case of AML, it was proposed that chromatin modification resulted from the targeting of the sFRP1 gene by the RUNXETO fusion protein (Cheng et al. 2011b).”
BackgroundTargeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Ni, M., Chen, Y., Lim, E., Bailey, S. T., Imai, Y., Liu, X. S., & Brown, M. A. (2011) · The Endocrine Society eBooks · doi:10.1210/endo-meetings.2011.part1.p3.p1-48 · Cited by 14
Wilms tumor suppressor WTX negatively regulates WNT/β-catenin signaling
Arceci, R. J. (2008) · Yearbook of Oncology · doi:10.1016/s1040-1741(08)79176-0 · Cited by 4
The WTX Tumor Suppressor Regulates Mesenchymal Progenitor Cell Fate Specification
Moisan, A., Rivera, M. N., Lotinun, S., Akhavanfard, S., Coffman, E. J., Cook, E., Stoykova, S., Mukherjee, S., Schoonmaker, J. A., Burger, A., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.04.017 · Cited by 1
Cited by
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
The complex world of WNT receptor signalling
Niehrs, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3470 · Cited by 1,492
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Liu, J., Pan, S., Hsieh, M. H., Ng, N., Sun, F., Wang, T., Kasibhatla, S., Schuller, A. G., Li, A. G., Cheng, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314239110 · Cited by 831
“In addition, overexpression of Wnt ligands or costimulants, such as R-Spondin 2/3 (RSPO2/3), or silencing of Wnt inhibitor genes has been reported in various cancers (1, 4).”
BackgroundInfluentialScientific Opinion on acrylamide in food
(CONTAM), E. P. O. C. I. T. F. C. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.4104 · Cited by 828
“The deregulation of this pathway has been reported in different malignancies (Polakis, 2012).”
BackgroundSustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
Metadata
- Authors
- Polakis, P.
- Affiliations
- Genentech (US)
- Corresponding author
- Polakis, P.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-03-20
- Volume
- 4
- Issue
- 5
- Pages
- a008052-a008052
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC3331705
- OpenAlex
- W2149598894
- Cited by
- 847
- References
- 94
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 41 · 2023: 36 · 2022: 56 · 2021: 85 · 2020: 76 · 2019: 77 · 2018: 76 · 2017: 95 · 2016: 89 · 2015: 64 · 2014: 54 · 2013: 51 · 2012: 13
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Wnt signaling, cancer, epigenetic regulation, Wnt inhibitors, malignant transformation, tumor genome sequencing
- MeSH terms
- Humans, Models, Biological, Mutation, Neoplasms, Oncogene Proteins, Tumor Suppressor Proteins, Epigenesis, Genetic, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.